ID
33286
Description
Study ID: 107806 Clinical Study ID: RA3107806 Study Title: An open label study to determine the safety, tolerability, excretion balance and pharmacokinetics of Losmapimod, administered as a single dose of an oral solution to healthy adult male subjects Patient Level Data: Clinicaltrials.gov Identifier: NCT00599612 https://clinicaltrials.gov/ct2/show/NCT00599612 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: losmapimod Trade Name: losmapimod Study Indication: Pulmonary Disease, Chronic Obstructive The study consists of a screening, study visit and follow-up. The protocol identifier for all: RA3107806 This document contains the Electronically transferred laboratory data form (Clinial chemistry, haematology, urinanalysis). It has to be filled in for sceening, study visit and follow up. If the laboratory results meet the protocol definition of an adverse event, record the details in the Non-Serious Adverse Events or Serious Adverse Event section(s).
Link
https://clinicaltrials.gov/ct2/show/NCT00599612
Keywords
Versions (1)
- 12/4/18 12/4/18 -
Copyright Holder
GlaxoSmithKline
Uploaded on
December 4, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Safety, tolerability, excretion balance and pharmacokinetics of Losmapimod in healthy males, NCT00599612
Electronically transferred laboratory data
- StudyEvent: ODM
Similar models
Electronically transferred laboratory data
- StudyEvent: ODM
C0008000 (UMLS CUI-2)
C0008000 (UMLS CUI [1,2])
C0018941 (UMLS CUI-2)
C0018941 (UMLS CUI [1,2])
C0042014 (UMLS CUI-2)
C0042014 (UMLS CUI [1,2])